HCPCS Level IIdrugActive
J2357
Omalizumab injection
BETOS: O1E
Effective: 2005-01-01
Referenced in 1 policies
Description
Injection, omalizumab, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Xolair
Manufacturer
Genentech, Inc.
HCPCS Dosage
5 MG
Billing Units
30.0000
9
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.